Investors take a calculated risk on Omega Diagnostics as ‘COVID stocks’ bounce back

The share price of Omega Diagnostics saw one of its biggest intraday gains in recent weeks with a 17 percent surge by the early afternoon.

Buoyed by a share price in excess of 70 percent for Abgingdon Health following a market update today ( Abingdon Health BioSURE progress boosts shares in testing times ) – investors appeared to pile back into Omega Diagnostics in the hope that a similar positive announcement would considerably lift the share price up from their recent lows of around 40p.

Omega Diagnostics has not issued a a market update and has been quiet on social media as investors await for confirmation of the government selecting a suitable COVID-19 test to put through its production line ( Omega Diagnostics CEO promises very exciting times as confirms landmark government deal ).

The last meaningful update from Omega Diagnostics was that it had taken delivery of government-loaned equipment in anticipation of a suitable lateral flow test being put through its production line upon instruction of the government:

A calculated risk by investors as ‘COVID stocks’ bounce back from lows

Buying back into Omega Diagnostics shares appears to be a calculated risk by investors. In recent weeks it has seen three other popular ‘COVID stocks’ bounce back following positive but not transformational news.

The controversial Remote Monitored Systems saw its share price soar 50 percent alone with a thinly-veiled mention of a distribution agreement for its face mask in India and Abingdon Health has soared 70 percent on news that a rapid antibody test is ready to launch that it manufactures.

Likewise, Novacyt has seen a solid recovery in recent weeks as it posted promising revenue guidance and less reliance on DHSC revenues ( Novcacyt share price soars once more as non-DHSC revenue grows ).

What investors appear to be buying in Omega Diagnostics is firstly that there is still demand for ‘COVID stocks’ and amplified gains following recent lows as the aforementioned movements in share price show.

Secondly, hope remains that Omega Diagnostics will announce that the government has finally selected a test to put through its production line.

Daily Movers

Let's Talk

Buying Abingdon Health shares - w …Great interview - thanks. Prospects look good and not definitely n … Read More
Holding or selling ODX shares? Pr …That update looks like it saved it up from 40p! Would look foolish … Read More
Does Aquis do RNS announcements£270 per announcement that's mad!??! Would definitely make se … Read More
Buying Tremor SharesNot the end of the world; £8 now so not the best short term gain Read More
BOTB share price target at £14 - …Haven't seen the report but suppose if they invest wisely and … Read More
Hey, profit awaits! Free Sharebuyers Newsletter

Receive hot tips you can profit from - only sent when it matters. Twitter: @ShareBuyers.